UV Clinical A/S: Financial statements 2018
CVR: 38401572
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
UV Clinical A/S (CVR 38401572) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 3,701 and a net result of DKK -798,697 compared with DKK -1,115,384 the year before. Equity in the 2018 report amounted to DKK -584,081. The company had 1 employee in the financial year.
- Gross Profit
- DKK 3,701
- Profit/Loss
- DKK -798,697
- Equity
- DKK -584,081
- Total Assets
- DKK 1,329,194
- Employees
- 1
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
UV Clinical A/S has published its annual report for 2017. Gross profit came to DKK -376,405, and the net result was DKK -1,115,384.
As of February 27, 2018, Helge Holm-Larsen has joined the board of directors of UV Clinical A/S.
As of February 27, 2018, Anne Sophie Winther Hansen has left the board of directors of UV Clinical A/S.
About UV Clinical A/S
UV Clinical A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 2017. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named UV Clinical ApS. The management consists of Rolf Henrik Sprunk-Jansen. The board consists of Helge Holm-Larsen (chair), Emilio de la Guardia Gascuñana and Rolf Henrik Sprunk-Jansen. The company is owned by Ulstrup Invest ApS, Canajo Invest ApS and Holafa ApS. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK 1,274,253 and a net result of DKK -1,282,165 compared with DKK -1,895,100 the year before. Equity in the 2025 report amounted to DKK 22,796,335.